semaglutide merck seeks GLP-1 drugs with benefits beyond weight loss - CEO OZEMPIC® (semaglutide) | Inj |

Some effects like nausea or digestive changes can catch you off guard and make sticking to your plan harder than it should be

Supports Skin Health & Radiance Promotes healthy-looking skin and overall skin wellness

Average weight loss after 48 weeks included: 1 mg dose: about 8.7% body-weight reduction 4 mg dose: about 17.1% reduction 8 mg dose: about 22.8% reduction 12 mg dose: about 24.2% reduction Placebo: about 2.1% reduction These results represented one of the largest average weight reductions reported for an antiobesity medication in a randomized clinical trial

The 5mg in 2ml dosage chart is the standard reference most researchers use